Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
Patients are increasingly asked to play a role in lowering the cost of medical imaging. However, without easy access to information about cost and quality, selecting the best diagnostic imaging provider is difficult if not downright impossible.
A joint venture between GE Healthcare and Microsoft aimed at building a new software platform for health care IT could make electronic health records more useful by pulling together patient data from different systems.
The National Institutes of Health recently awarded a $2.25 million grant to Heart IT and Johns Hopkins University to develop a method for accessing images using the Nationwide Health Information Network (NHIN).
New research presented at this year’s RSNA conference suggests that women in their 40s should in fact receive mammography screening even if they have no family history of breast cancer despite current U.S. guidelines to the contrary.
A study published in the November 14 issue of Radiology punched a hole in the theory that self-referring radiologists drive up medical costs through follow-up exams.
Varian Medical Systems recently won Food and Drug Administration approval for two innovations that should improve targeted radiotherapy for treating breast cancer.
The research firm KLAS reports that nearly 1 in 6 hospitals with more than 1,000 beds plan to replace their PACS system. Most hospitals, however, are more focused on meeting meaningful use criteria, based on a survey conducted by the firm.